雜志介紹

Personalized Medicine雜志介紹

《Personalized Medicine》是一本以English為主的未開放獲取國際優秀期刊，中文名稱個性化醫療，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.7，最新CiteScore 指數為3.3。

本刊近期中國學者發表的論文主要有：

• The association study of CLOCK gene polymorphisms with antidepressant effect in Chinese with major depressive disorder.

  Author: Ma HY¹, Liu ZF², Xu YF¹, Hu XD¹, Sun N¹, Li XR¹, Zhang KR¹.

• Screening of NogoA/NTR-related differential genes in rat sciatic nerve injury signal pathway.

  Author: Jiang J¹, Zhang Z¹, Yu Y¹, Luan M¹, Ma Z¹, Gao F¹, Yu S¹.

• Toward multiomics-based next-generation diagnostics for precision medicine.

  Author: Wang Q¹, Peng WX¹, Wang L¹, Ye L².

• Using clinical genomic sequencing to guide personalized cancer therapy in China.

  Author: Bai Y¹, Wang G², Wei J², Dai C², Xu X², Cai X², Wu B², Sun W², Xu Q², Jiao S³.

英文介紹

Personalized Medicine雜志英文介紹

Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis.

The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.